Teladoc Health Sees Q2 GAAP EPS $(0.30)-$(0.20) vs $(0.23) Est; Sees Sales $597.000M-$626.000M vs $623.670M Est.

Benzinga Newsdesk www.benzinga.com Neutral 46.0%

Neg 0% Neu 46% Pos 0%

Teladoc Health (NYSE:TDOC) is looking for Q2 GAAP EPS of $(0.30)-$(0.20) vs $(0.23) analyst estimate. sees sales of $597.000 million-$626.000 million vs $623.670 million analyst estimate.